Try a new search

Format these results:

Searched for:

Department/Unit:Cell Biology

Total Results:

14243


Erratum: Early Events in the Endoplasmic Reticulum Unfolded Protein Response

Preissler, Steffen; Ron, David
PMID: 30510064
ISSN: 1943-0264
CID: 3678282

Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs

Gonzalez, Pedro Luis; Rappo, Urania; Akinapelli, Karthik; McGregor, Jennifer S; Puttagunta, Sailaja; Dunne, Michael W
Background/UNASSIGNED:Persons who inject drugs (PWID) are at increased risk of acute bacterial skin and skin structure infections (ABSSSIs), a growing healthcare concern. Multiple medical, social, and economic issues, including adherence and comorbidities, complicate the medical care of the PWID population, adversely affecting patient outcomes. Methods/UNASSIGNED:We assessed demographics and outcomes for the PWID population in a double-blind trial of 698 patients randomized to dalbavancin 1500 mg as a single intravenous (IV) infusion or as a 2-dose regimen (1000 mg IV on day 1; 500 mg IV on day 8) for ABSSSI. The primary endpoint was ≥20% reduction in erythema at 48-72 hours in the intent-to-treat population; clinical status was also assessed at days 14 and 28. Results/UNASSIGNED:There were 212/698 (30.4%) patients with a history of injection drug use in this clinical trial. Dalbavancin efficacy was similar between the single- and 2-dose therapy groups in the PWID and non-PWID populations at all timepoints. Dalbavancin was well tolerated in the PWID population, with similar rates of adverse events as the non-PWID population. Conclusion/UNASSIGNED:Dalbavancin as a single-dose or 2-dose regimen had similar efficacy for the treatment of ABSSSI at all timepoints in the PWID and non-PWID populations. A single 30-minute IV infusion would eliminate the need for indwelling IV access. The convenience of a single dose supervised in a health setting may also optimize treatment adherence in the PWID population.
PMCID:6292452
PMID: 30574170
ISSN: 1745-1981
CID: 3680042

Adenylyl Cyclase 6 Mediates Inhibition of TNF in the Inflammatory Reflex

Tarnawski, Laura; Reardon, Colin; Caravaca, April S; Rosas-Ballina, Mauricio; Tusche, Michael W; Drake, Anna R; Hudson, LaQueta K; Hanes, William M; Li, Jian Hua; Parrish, William R; Ojamaa, Kaie; Al-Abed, Yousef; Faltys, Michael; Pavlov, Valentin A; Andersson, Ulf; Chavan, Sangeeta S; Levine, Yaakov A; Mak, Tak W; Tracey, Kevin J; Olofsson, Peder S
Macrophage cytokine production is regulated by neural signals, for example in the inflammatory reflex. Signals in the vagus and splenic nerves are relayed by choline acetyltransferase+ T cells that release acetylcholine, the cognate ligand for alpha7 nicotinic acetylcholine subunit-containing receptors (α7nAChR), and suppress TNF release in macrophages. Here, we observed that electrical vagus nerve stimulation with a duration of 0.1-60 s significantly reduced systemic TNF release in experimental endotoxemia. This suppression of TNF was sustained for more than 24 h, but abolished in mice deficient in the α7nAChR subunit. Exposure of primary human macrophages and murine RAW 264.7 macrophage-like cells to selective ligands for α7nAChR for 1 h in vitro attenuated TNF production for up to 24 h in response to endotoxin. Pharmacological inhibition of adenylyl cyclase (AC) and knockdown of adenylyl cyclase 6 (AC6) or c-FOS abolished cholinergic suppression of endotoxin-induced TNF release. These findings indicate that action potentials in the inflammatory reflex trigger a change in macrophage behavior that requires AC and phosphorylation of the cAMP response element binding protein (CREB). These observations further our mechanistic understanding of neural regulation of inflammation and may have implications for development of bioelectronic medicine treatment of inflammatory diseases.
PMCID:6277584
PMID: 30538698
ISSN: 1664-3224
CID: 3678962

Comparison of vitamin D metabolites in wild and captive baboons

Ziegler, Toni E; Kapoor, Amita; Binkley, Neil C; Rice, Karen S; Rogers, Jeffrey; Jolly, Clifford J; Phillips-Conroy, Jane E
Vitamin D adequacy is essential for multiple physiologic processes. With limited exposure to sunlight for vitamin D3 synthesis, captive primates are supplemented with vitamin D3 (cholecalciferol). Vitamin D metabolite data from wild primates living indigenously could suggest optimum levels. The purpose of this study was to: 1) to explore whether baboons, a speciose genus whose members have significant exposed skin, coat color variation and wide geographical distribution, mirrors the skin pigmentation-vitamin D relationship found in humans; 2) compare vitamin D metabolite levels in wild and captive members of the same or similar baboon species; and 3) apply a recently developed method currently used in humans for measuring multiple vitamin D metabolites as a panel to explore if/how these metabolites can inform us on vitamin D sufficiency. Serum samples from males of three baboon species in the wild: Papio anubis (olive baboon, dark exposed skin), P. cynocephalus (yellow baboon, brown exposed skin), and P. hamadryas (hamadryas baboon, pink exposed skin), were compared with vitamin D supplemented captive olive baboons with sun exposure. Liquid chromatography/tandem mass spectrometry (LC/MS/MS) measured vitamin D and its main metabolites. Cholecalciferol, 25 hydroxyvitamin D2&3 (25(OH)D2&3 ), and 24,25 dihydroxyvitamin D2&3 (24,25(OH)2 D2&3 ), showed significant differences by species. The levels of cholecalciferol due to supplements in the captive olive baboons did not convert to higher 25(OH)D3 while the wild olive baboons exhibited the lowest levels for both cholecalciferol and 25(OH)D3 . Further metabolic conversion of 25(OH)D3 to 24,25(OH)2 D3 indicated that all baboons had more similar conversion ratios and these were within the same range found for humans that are depicted as having adequate vitamin D levels. This study provided evidence that exposed skin color does influence vitamin D3 levels, with lower levels in darker skinned species, but these differences are eliminated in the downstream metabolite conversion indicating strong regulatory control.
PMID: 30537386
ISSN: 1098-2345
CID: 3659282

Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer

Lee, Pei-Chih; Fang, Yueh-Fu; Yamaguchi, Hirohito; Wang, Wei-Jan; Chen, Tse-Ching; Hong, Xuan; Ke, Baozhen; Xia, Weiya; Wei, Yongkun; Zha, Zhengyu; Wang, Yan; Kuo, Han-Pin; Wang, Chih-Wei; Tu, Chih-Yen; Chen, Chia-Hung; Huang, Wei-Chien; Chiang, Shu-Fen; Nie, Lei; Hou, Junwei; Chen, Chun-Te; Huo, Longfei; Yang, Wen-Hao; Deng, Rong; Nakai, Katsuya; Hsu, Yi-Hsin; Chang, Shih-Shin; Chiu, Tai-Jan; Tang, Jun; Zhang, Ran; Wang, Li; Fang, Bingliang; Chen, Ting; Wong, Kwok-Kin; Hsu, Jennifer L; Hung, Mien-Chie
Multiple mechanisms of resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been identified in EGFR-mutant non-small cell lung cancer (NSCLC); however, recurrent resistance to EGFR TKIs due to the heterogeneous mechanisms underlying resistance within a single patient remains a major challenge in the clinic. Here, we report a role of nuclear protein kinase Cδ (PKCδ) as a common axis across multiple known TKI-resistance mechanisms. Specifically, we demonstrate that TKI-inactivated EGFR dimerizes with other membrane receptors implicated in TKI resistance to promote PKCδ nuclear translocation. Moreover, the level of nuclear PKCδ is associated with TKI response in patients. The combined inhibition of PKCδ and EGFR induces marked regression of resistant NSCLC tumors with EGFR mutations.
PMID: 30537515
ISSN: 1878-3686
CID: 3659292

Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts

LeBlanc, Erin S; Pratley, Richard E; Dawson-Hughes, Bess; Staten, Myrlene A; Sheehan, Patricia R; Lewis, Michael R; Peters, Anne; Kim, Sun H; Chatterjee, Ranee; Aroda, Vanita R; Chadha, Chhavi; Neff, Lisa M; Brodsky, Irwin G; Rosen, Clifford; Desouza, Cyrus V; Foreyt, John P; Hsia, Daniel S; Johnson, Karen C; Raskin, Philip; Kashyap, Sangeeta R; O'Neil, Patrick; Phillips, Lawrence S; Rasouli, Neda; Liao, Emilia P; Robbins, David C; Pittas, Anastassios G
OBJECTIVE:To describe baseline characteristics of the Vitamin D and Type 2 Diabetes (D2d) study, the first large U.S. diabetes prevention clinical trial to apply current American Diabetes Association (ADA) criteria for prediabetes. RESEARCH DESIGN AND METHODS:) 5.7-6.4% (39-46 mmol/mol). RESULTS:and FPG concentrations. CONCLUSIONS:D2d will establish whether vitamin D supplementation lowers risk of diabetes and will inform about the natural history of prediabetes per contemporary ADA criteria.
PMCID:6054501
PMID: 29941495
ISSN: 1935-5548
CID: 3657372

Novel Imaging Techniques in Cardiac Ion Channel Researc

Chapter by: Agullo-Pascual, Esperanza; Leo-Macias, Alejandra; Whelan, Donna R; Delmar, Mario; Rothenberg, Eli
in: Channelopathies in heart disease by Thomas, Dierk; Remme, Carol Ann (Eds)
Cham, Switzerland : Springer, [2018]
pp. 361-378
ISBN: 9783319778112
CID: 3614282

Unraveling the roles of apocrine sweat glands in Hidradenitis Suppurativa [Meeting Abstract]

Lu, C.
ISI:000452630300122
ISSN: 0906-6705
CID: 3558192

Brain-penetrant heat shock protein amplifier arimoclomol enhances GCase activity in in vitro Gaucher disease models

Hettinghouse, Aubryanna; Liu, Chuan-Ju
PMID: 30522930
ISSN: 2352-3964
CID: 3560002

Blockade of the Adenosine 2A Receptor Mitigates the Cardiomyopathy Induced by Loss of Plakophilin-2 Expression

Cerrone, Marina; van Opbergen, Chantal J M; Malkani, Kabir; Irrera, Natasha; Zhang, Mingliang; Van Veen, Toon A B; Cronstein, Bruce; Delmar, Mario
Background: Mutations in plakophilin-2 (PKP2) are the most common cause of familial Arrhythmogenic Right Ventricular Cardiomyopathy, a disease characterized by ventricular arrhythmias, sudden death, and progressive fibrofatty cardiomyopathy. The relation between loss of PKP2 expression and structural cardiomyopathy remains under study, though paracrine activation of pro-fibrotic intracellular signaling cascades is a likely event. Previous studies have indicated that ATP release into the intracellular space, and activation of adenosine receptors, can regulate fibrosis in various tissues. However, the role of this mechanism in the heart, and in the specific case of a PKP2-initiated cardiomyopathy, remains unexplored. Objectives: To investigate the role of ATP/adenosine in the progression of a PKP2-associated cardiomyopathy. Methods: HL1 cells were used to study PKP2- and Connexin43 (Cx43)-dependent ATP release. A cardiac-specific, tamoxifen-activated PKP2 knock-out murine model (PKP2cKO) was used to define the effect of adenosine receptor blockade on the progression of a PKP2-dependent cardiomyopathy. Results: HL1 cells silenced for PKP2 showed increased ATP release compared to control. Knockout of Cx43 in the same cells blunted the effect. PKP2cKO transcriptomic data revealed overexpression of genes involved in adenosine-receptor cascades. Istradefylline (an adenosine 2A receptor blocker) tempered the progression of fibrosis and mechanical failure observed in PKP2cKO mice. In contrast, PSB115, a blocker of the 2B adenosine receptor, showed opposite effects. Conclusion: Paracrine adenosine 2A receptor activation contributes to the progression of fibrosis and impaired cardiac function in animals deficient in PKP2. Given the limitations of the animal model, translation to the case of patients with PKP2 deficiency needs to be done with caution.
PMCID:6290386
PMID: 30568602
ISSN: 1664-042x
CID: 3556692